VEGF in physiological process and thyroid disease.

@article{Klein2007VEGFIP,
  title={VEGF in physiological process and thyroid disease.},
  author={Marc Klein and Bogdan Catargi},
  journal={Annales d'endocrinologie},
  year={2007},
  volume={68 6},
  pages={
          438-48
        }
}
Angiogenesis is a physiological process involving the growth of new vessels from pre-existing vasculature. Vascular endothelial growth factor (VEGF) is an important regulator of both benign and malignant disease processes in the thyroid gland. The VEGF family includes seven members respectively named VEGF-A, also known as VPF (vascular permeability factor), VEGF-B, VEGF-C, VEGF-D, all described in mammals, VEGF-E (found in Parapoxviridae), VEGF-F (also called svVEGF, for snake venom VEGF, found… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 10 CITATIONS

Association of thyroid status prior to transition to end-stage renal disease with early dialysis mortality.

  • Amy S. You, John J Sim, +5 authors Connie M. Rhee
  • Medicine
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • 2018
VIEW 1 EXCERPT
CITES METHODS

References

Publications referenced by this paper.
SHOWING 1-10 OF 127 REFERENCES

Angiogenesis and cancer prevention: a vision.

Recombinant human thyrotropin stimulates thyroid angiogenesis in vivo.

Expression of vascular endothelial growth factor ( VEGF ) and its receptors in thyroid carcinomas of follicular origin : a potential autocrine loop

  • J Vieira, S RosaSantos, +3 authors C Casalou
  • Eur J Endocrinol
  • 2005

Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases

  • Yu X-M, Lo C-Y, +3 authors J Luk
  • Clin Cancer Res
  • 2005